Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

619 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Immediate versus staged complete revascularization in patients presenting with multivessel disease and ST- or non-ST-segment elevation acute coronary syndrome.
Elscot JJ, Kakar H, den Dekker WK, Bennett J, Sabaté M, Esposito G, Boersma E, McFadden E, Garcia-Garcia HM, Van Mieghem NM, Diletti R; BIOVASC investigators. Elscot JJ, et al. Among authors: mcfadden e. Int J Cardiol. 2025 Jun 12:133496. doi: 10.1016/j.ijcard.2025.133496. Online ahead of print. Int J Cardiol. 2025. PMID: 40516659
[Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory].
Spitzer E, de la Torre Hernández JM, Guðmundsdóttir IJ, McFadden E, Held C, Hanet C, Boersma E, Ren CB, Delgado V, Erlinge D, Pérez de Prado A, Bax JJ, Tijssen JGP. Spitzer E, et al. Among authors: mcfadden e. REC Interv Cardiol. 2024 May 27;6(3):213-223. doi: 10.24875/RECIC.M24000445. eCollection 2024 Jul-Sep. REC Interv Cardiol. 2024. PMID: 40415770 Free PMC article. Review. Spanish.
New Approach Methods (NAMs) for genotoxicity assessment of nano- and advanced materials; Advantages and challenges.
Gutleb AC, Murugadoss S, Stępnik M, SenGupta T, El Yamani N, Longhin EM, Olsen AH, Wyrzykowska E, Jagiello K, Judzinska B, Cambier S, Honza T, McFadden E, Shaposhnikov S, Puzyn T, Serchi T, Weber P, Arnesdotter E, Skakalova V, Jirsova K, Grudzinski IP, Collins A, Rundén-Pran E, Dusinska M. Gutleb AC, et al. Among authors: mcfadden e. Mutat Res Genet Toxicol Environ Mutagen. 2025 May-Jun;904:503867. doi: 10.1016/j.mrgentox.2025.503867. Epub 2025 Mar 30. Mutat Res Genet Toxicol Environ Mutagen. 2025. PMID: 40382189 Review.
Polymer-free versus biodegradable-polymer drug-eluting stent in patients undergoing percutaneous coronary intervention: an assessor-blind, non-inferiority, randomised controlled trial.
Piccolo R, Calabrò P, Carrara G, Varricchio A, Baldi C, Napolitano G, De Simone C, Mauro C, Stabile E, Caiazzo G, Tesorio T, Boccalatte M, Tuccillo B, Cirillo P, Di Serafino L, Simonetti F, Leone A, Angellotti D, Bottiglieri G, Russolillo E, Galasso G, Perrotta R, Cesaro A, Niglio T, Capasso M, Spinelli A, Cristiano S, Faretra A, Bruzzese D, Chieffo A, Tarantini G, Leonardi S, Biscaglia S, Costa F, Cassese S, McFadden E, Heg D, Franzone A, Stefanini GG, Capodanno D, Esposito G, Parthenope Investigators FT. Piccolo R, et al. Among authors: mcfadden e. EuroIntervention. 2025 Jan 6;21(1):58-72. doi: 10.4244/EIJ-D-24-00657. EuroIntervention. 2025. PMID: 39773824 Free article. Clinical Trial.
Timing of Complete Multivessel Revascularization in Acute Coronary Syndrome: 2-Year Results of the BIOVASC Study.
den Dekker WK, Elscot JJ, Bennett J, Schotborgh CE, van der Schaaf R, Sabaté M, Moreno R, Ameloot K, van Bommel R, Forlani D, van Reet B, Esposito G, Dirksen MT, Ruifrok WPT, Everaert BRC, Van Mieghem C, Cummins P, Lenzen M, Brugaletta S, Boersma E, Van Mieghem NM, Diletti R; BIOVASC Investigators. den Dekker WK, et al. JACC Cardiovasc Interv. 2024 Dec 23;17(24):2866-2874. doi: 10.1016/j.jcin.2024.09.058. JACC Cardiovasc Interv. 2024. PMID: 39722269 Free article. Clinical Trial.
Abbreviated or Standard Antiplatelet Therapy After PCI in Diabetic Patients at High Bleeding Risk.
Roffi M, Landi A, Heg D, Frigoli E, Chalkou K, Chevalier B, Ijsselmuiden AJJ, Kastberg R, Komiyama N, Morice MC, Onuma Y, Ozaki Y, Peace A, Pyxaras S, Sganzerla P, Williams R, Xaplanteris P, Vranckx P, Windecker S, Smits PC, Valgimigli M; MASTER DAPT Investigators. Roffi M, et al. JACC Cardiovasc Interv. 2024 Nov 25;17(22):2664-2677. doi: 10.1016/j.jcin.2024.08.030. JACC Cardiovasc Interv. 2024. PMID: 39603779 Clinical Trial.
De-escalation to ticagrelor monotherapy versus 12 months of dual antiplatelet therapy in patients with and without acute coronary syndromes: a systematic review and individual patient-level meta-analysis of randomised trials.
Valgimigli M, Hong SJ, Gragnano F, Chalkou K, Franzone A, da Costa BR, Baber U, Kim BK, Jang Y, Chen SL, Stone GW, Hahn JY, Windecker S, Gibson MC, Song YB, Ge Z, Vranckx P, Mehta S, Gwon HC, Lopes RD, Dangas GD, McFadden EP, Angiolillo DJ, Leonardi S, Heg D, Calabrò P, Jüni P, Mehran R, Hong MK; Single Versus Dual Antiplatelet Therapy (Sidney-4) collaborator group. Valgimigli M, et al. Among authors: mcfadden ep. Lancet. 2024 Sep 7;404(10456):937-948. doi: 10.1016/S0140-6736(24)01616-7. Epub 2024 Aug 31. Lancet. 2024. PMID: 39226909
619 results